THE TIMING OF PLERIXAFOR ADMINISTRATION MODULATES THE GRAFT COMPOSITION OF MM PATIENTS UNDERGOING STEM CELL MOBILIZATION WITH CY AND G-CSF: BIOLOGICAL AND CLINICAL RESULTS OF A PHASE IV MULTICENTER STUDY

HAEMATOLOGICA(2017)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要